Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Biocon Ltd

NSE: BIOCON · BSE: 532523 · Pharmaceuticals & Biotechnology · 57 announcements

Biocon Ltd news stories on ALFA NewsRead the news →
Share price
₹360.70
Market cap
₹58,783 Cr
Revenue (annual)
₹16,927 Cr
Net profit (annual)
₹385.6 Cr
P/E (TTM)
118.7×Sector 47.4×
Promoter holding
44.68%-0.23% QoQ
FII holding
8.14%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Regulatory Approval 6Earnings Call 6Annual General Meeting 6Other Announcement 4Capital Structure Change 4Business Update 4New Order Win 3Management Change 3Fund Raise 3Financial Results 3Results Update 2Product Launch 2Merger & Restructuring 2Board Meeting Outcome 2Board Meeting Date 2Acquisition 2Price Movement Clarification 1Dividend 1Annual Report 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

2 announcements with these filters

19:43 IST BSE
Acquisition

Biocon Acquisition Worth ₹5.48 Cr

Biocon invested Rs.5.48 Crore for a 37.77% stake in Ampin C&I Power Twelve, a solar SPV. This supports its renewable energy goals and reduces carbon footprint.

Value
₹5.48 Cr
Read the filing ↗
20:25 IST NSE
Acquisition

Biocon Acquisition Worth ₹330.7 Cr

Biocon will acquire a minority stake in Biocon Biologics for ₹330.73 Crore via share-swap. The deal consolidates BBL as a wholly owned subsidiary by June 2026.

Value
₹330.7 Cr
Execution
30/06/2026
Read the filing ↗